• Nenhum resultado encontrado

Correction: Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells.

N/A
N/A
Protected

Academic year: 2017

Share "Correction: Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells."

Copied!
1
0
0

Texto

(1)

CORRECTION

Correction: Glucocorticoids Inhibit Basal and

Hormone-Induced Serotonin Synthesis in

Pancreatic Beta Cells

Moina Hasni Ebou, Amrit Singh-Estivalet, Jean-Marie Launay, Jacques Callebert,

François Tronche, Pascal Ferré, Jean-François Gautier, Ghislaine Guillemain,

Bernadette Bréant, Bertrand Blondeau, Jean-Pierre Riveline

Fig 4

and its caption appear incorrectly in the published article. Please see the correct

Fig 4

and

its caption here.

Reference

1. Hasni Ebou M, Singh-Estivalet A, Launay J-M, Callebert J, Tronche F, Ferré P, et al. (2016) Glucocorti-coids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells. PLoS ONE 11 (2): e0149343. doi:10.1371/journal.pone.0149343PMID:26901633

Fig 4. GCs inhibit liraglutide-induced increase of serotonin contents in vivo.Serotonin contents measured on isolated islets of mice treated with vehicle only (Veh, white bar), liraglutide (Lira, black bar), corticosterone (Cort, dark grey) or both liraglutide and corticosterone (Lira+Cort, light gray) for 4 weeks. Results are expressed as means±SD for n = 5 mice in each group.*p<0.05**and p<0.01 when comparing the different groups using a ANOVA test.

doi:10.1371/journal.pone.0155174.g001

PLOS ONE | DOI:10.1371/journal.pone.0155174 May 4, 2016 1 / 1

a11111

OPEN ACCESS

Citation:Ebou MH, Singh-Estivalet A, Launay J-M, Callebert J, Tronche F, Ferré P, et al. (2016) Correction: Glucocorticoids Inhibit Basal and Hormone-Induced Serotonin Synthesis in Pancreatic Beta Cells. PLoS ONE 11(5): e0155174. doi:10.1371/ journal.pone.0155174

Published:May 4, 2016

Copyright:© 2016 Ebou et al. This is an open access article distributed under the terms of the

Imagem

Fig 4 and its caption appear incorrectly in the published article. Please see the correct Fig 4 and its caption here.

Referências

Documentos relacionados

(A) Protein extracts from the dorsal horn of the spinal cord of control mice (sham; sh) and CCI-mice treated with vehicle (VEH) and 50 mg/Kg of EGCG, compound 23 (c23) and compound

To test this directly, the authors exam- ined mice lacking tryptophan hydroxylase, a key enzyme in serotonin synthesis, rendering the mice unable to make serotonin outside the

The present study was designed to evaluate the differences in the coronary vasodilator actions of serotonin (5-HT) in isolated heart obtained from naive or castrated male and

Acrolein (ACR) (75 µg/bladder)-induced increase in bladder wet weight and Evans blue extravasation were measured 3 h after the induction of cystitis in mice treated with

Two approaches based on partition equilibrium, stir bar sorptive extraction (SBSE) and microextraction by packed sorbent (MEPS) were evaluated for determination of selective serotonin

Methodology: Platelet and plasma unconjugated concentrations of serotonin and plasma 5-HIAA, the major serotonin metabolite, levels were measured using HPLC with coulometric

Fig 2. Base-case scatter plots generated for of 1000 type 2 diabetes patients treated with liraglutide vs.. QALYs with liraglutide. Tzanetakos et al. exenatide resulted in

Effect of human growth hormone- releasing hormone on GH secretion in Cushing’s syn- drome and non-endocrine disease patients treated with glucocorticoids.. Leal-Cerro A, Pereira